Atlas Trials

Prediction of Drug Response Using an Ex Vivo Organ Culture (EVOC) on Fresh Human Tumour Samples From Metastatic Patients

Clinical trial NCT04599608 · UNKNOWN

Trial details

NCT number
NCT04599608
Sponsor
Imperial College London
Status
UNKNOWN
Study type
OBSERVATIONAL
Advanced CancerMetastatic Cancer
Start date
2021-02-01
Primary completion
2024-02-01
Enrollment
248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.